This aspect, which will be discussed in the next paragraph in the context of non-canonical mechanisms of ErbB signaling, can also be partly responsible for the discordant data regarding ErbB4 as prognostic marker for HNSCC. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.